This research review examines how climate change and extreme weather increase morbidity across major organ systems. It highlights how rising temperatures and humidity compromise pharmaceutical stability and efficacy, particularly for vulnerable populations. The report calls for updated clinical guidelines and climate-resilient pharmaceutical regulations to safeguard public health.

This advocacy document calls for targeted investment in the One Health Joint Plan of Action. The Quadripartite collaboration proposes a Joint Offer to support at least ten countries over five years, strengthening governance, multisectoral coordination, and sustainable financing to prevent and control global health risks effectively.

This research examines the financial case for investing in One Health to mitigate global health threats. It highlights how integrated approaches reduce costs and improve efficiencies. Through various global case studies, the report demonstrates significant economic returns and provides a strategic blueprint for future sustainable investment.

This report assesses the capacity of artificial intelligence and robots to automate ageing workforces across 135 economies. While automation could offset demographic pressures, its effectiveness is limited because ageing often occurs in sectors with low automation potential, such as health and agriculture, particularly in several fast-ageing advanced economies.

This report analyses sustainable investment trends for 2026, examining physical climate risk, the energy transition, and Asia’s leadership. It addresses the influence of artificial intelligence on power demand and emission targets, alongside structural challenges in the health care and food production sectors, highlighting resilience and adaptation as key priorities.

This report identifies the gender health gap as a systemic market failure and significant investment opportunity. Closing this gap could boost the global economy by US$1 trillion annually by 2040. In Australia, the opportunity is valued at US$24.8 billion per year, offering a time-limited ten-year window for investors.

An interactive tracker by The Good Food Institute mapping global regulatory approvals and market pathways for cultivated meat products.

This benchmark series is an annual State of the Industry series that provides a global overview of the cultivated meat, seafood and ingredients sector. It tracks commercial developments, investment activity, scientific and technological progress, consumer insights, and government and regulatory developments, assessing the sector’s progress towards large-scale commercialisation and adoption.

This report analyses the impact of extreme temperatures on respiratory mortality across 646 Brazilian municipalities from 2010 to 2020. Findings reveal a J-shaped exposure-response curve, with heat-related deaths dominating in tropical northern regions, whilst cold-related mortality predominates in the subtropical south, underscoring the need for region-specific climate adaptation policies.

This report examines the 34% of the global women's health gap caused by care delivery failures. Focusing on cardiovascular risk and perinatal depression, it outlines the CARE framework to standardise screening and referral pathways, demonstrating that preventative care investments yield a three- to six-fold return.

This report presents a comprehensive framework and toolkit to help governments and stakeholders manage extreme heat risk. It provides actionable guidance, a maturity assessment tool, and strategies to operationalise governance and develop effective heat action plans across multiple sectors and timescales.

Impax Asset Management reviews sustainability-driven trends shaping healthcare, highlighting AI-enabled productivity gains, regulatory pressures, and supply chain localisation. The report examines opportunities in healthcare equipment, life sciences and managed care, alongside risks from regulation, product liability, affordability concerns and geopolitical tensions.

McKinsey Health Institute (MHI) is a global health research institute embedded within McKinsey & Company. It produces public research, data tools and insights on population health, mental health, health systems and workforce productivity, supporting evidence-based decision-making across healthcare, policy and business.

Institute for Health Metrics and Evaluation (IHME) is an independent global health research institute based at University of Washington. IHME produces data, metrics and analysis on disease burden, mortality, risk factors and health systems, supporting evidence-based policy, planning and health impact assessment worldwide.

This report analyses the link between ESG integration and global investor returns, drawing on cross-regional data and sector comparisons. It assesses how environmental, social, and governance factors correlate with performance, highlighting variations across markets and asset classes. The study provides evidence-based insights on ESG’s financial materiality for investors worldwide.

Water Footprint Implementation supports companies and governments with water accounting, sustainability assessment and water-footprint compensation. A spin-off of Water Footprint Network research, it delivers actionable insights for ESG reporting, water stewardship, water-footprint benchmarking and tailored reduction strategies to enhance resilience, reduce risk and foster sustainable water management.